Publication | Open Access

Soluble Nogo-Receptor-Fc decoy (AXER-204) in patients with chronic cervical spinal cord injury in the USA: a first-in-human and randomised clinical trial

InflammationSpinal Cord InjuryHealth SciencesSpinal DisorderMedicinePain MedicineRandomised Clinical TrialSpinal TraumaNeuropathic PainRehabilitationSpinal InjuryNeurologyPain ManagementCervical SpineNeuropathologyNeuroimmunologySoluble Nogo-receptor-fc DecoyPain Research